Although the therapeutic investigation of tTF-NGR against CD13 was performed in the human fibrosarcoma cell line, the prothrombogenic effect in vivo of these fusion proteins was independent of tumor histology (Kessler et al., 2018). Here, ANPEP is linked to neoplasm.